Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss

PurposeTo establish a high-risk prediction model for aromatase inhibitor-associated bone loss (AIBL) in patients with hormone receptor-positive breast cancer.MethodsThe study included breast cancer patients who received aromatase inhibitor (AI) treatment. Univariate analysis was performed to identif...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Meiling Chu, Yue Zhou, Yulian Yin, Lan Jin, Hongfeng Chen, Tian Meng, Binjun He, Jingjing Wu, Meina Ye
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2023-04-01
Seri Bilgileri:	Frontiers in Oncology
Konular:	aromatase inhibitors breast cancer bone loss risk prediction model XGBoost logistic regression
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1182792/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss

Benzer Materyaller